BOXL vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

BOXL

38.3
AI Score
VS
UTI Wins

UTI

47.3
AI Score

Investment Advisor Scores

BOXL

38score
Recommendation
SELL

UTI

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BOXL UTI Winner
Revenue 48.36M 661.15M UTI
Net Income -6.02M 15.54M UTI
Net Margin -12.4% 2.4% UTI
Operating Income -3.87M 19.27M UTI
ROE 422.8% 4.5% BOXL
ROA -7.1% 1.7% UTI
Total Assets 84.35M 897.86M UTI
Cash 4.30M 130.06M UTI
Debt/Equity -23.98 0.46 BOXL
Current Ratio 0.94 1.30 UTI
Free Cash Flow -7.55M -63.50M BOXL

Relative Price Performance (Last 90 Days)

BOXL 1M: +55.9% · 3M: +614.6% UTI 1M: -42.2% · 3M: -38.9%

Current Technical Phase

BOXL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (60.5% over 20 days), RSI 56

RSI (14): 55.8 · Price: $5.66

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $22.35

Fundamentals Snapshot

Metric BOXL UTI
Market Cap
Forward P/E -0.1 30.4
Trailing P/E 39.5
Revenue (TTM)
Revenue Growth -0.2% 0.1%
Gross Margin 0.3% 0.6%
Operating Margin 0.0% 0.0%
EPS -150.52 0.58
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.